SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,810.00    115.00 (1.72%)
Bid:
6,770.00
Ask:
6,775.00
Spread: 5.00 (0.074%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Dividend Declaration

12 Mar 2025 07:00

RNS Number : 2741A
Spirax Group PLC
12 March 2025
Β 

Β 

12 March 2025

Β 

Spirax Group plc - Declaration of Final Dividend

Β 

As announced yesterday and in accordance with the LSE Dividend Procedure Timetable, Spirax Group plc confirms that the Board of Directors is proposing, subject to shareholder approval at the 2025 Annual General Meeting, a final dividend of 117.5 pence per share for 2024 (2023: 114.0 pence) payable on 23 May 2025 to shareholders on the register at 25 April 2025. Together with the interim dividend of 47.5 pence per share (2023: 46.0 pence), the total dividend for the year is 165.0 pence per share.

Issuer/Company Name

Spirax Group plc

Security/Securities

2612/13p Ordinary Shares

ISIN(s)

GB00BWFGQN14

TIDM(s)

SPX

Ex-Date

24 April 2025

Record Date

25 April 2025

Pay Date

23 May 2025

Dividend Type

Final

Dividend Amount

117.5 pence per share

Currency of Dividend payment

GBP

Β 

Enquiries:

Β 

Spirax Group: +44 (0) 1242 535 000

Mal Patel, Head of Investor Relations investors@spiraxgroup.com

Hazel Meldrum, Group Head of Communications communications@spiraxgroup.com

Β 

Teneo: +44 (0) 20 7260 2700

Martin Robinson spiraxgroup@teneo.com

Β 

Β About Spirax Group plc

Spirax Group (formerly Spirax-Sarco Engineering) is positioned to play a critical role in enabling the industrial transition to net zero, aligned to our Purpose to create sustainable value for all our stakeholders as we engineer a more efficient, safer and sustainable world. We put solving customers' problems at the heart of our 'total solutions' approach. Our global thermal energy and fluid technology solutions improve operating efficiency and safety in our customers' critical industrial processes. Our new-to-world decarbonisation* solutions will use our proprietary technologies to electrify boilers, for the raising of steam, as well as the electrification of other critical industrial process heating applications.

Spirax Group comprises three strong and aligned Businesses: Steam Thermal Solutions helps customers control and manage steam within their mission critical industrial applications, such as cleaning, sterilising, cooking and heating. We are helping to put food safely on the world's tables and keeping our hospitals running. Electric Thermal Solutions has proprietary technologies that deliver electrification solutions at scale in industrial settings, including for the raising of steam, supporting our customers to achieve their net zero goals. We also deliver freeze protection and defrost solutions critical to aviation and space industries and ensure thermal uniformity in Semiconductor chip manufacturing to power the critical electronic systems we rely on.Β  Watson‐Marlow Fluid Technology Solutions is engineering vital fluid technology solutions that optimise the efficient use of resources and support advancements in global health, such as lifesaving vaccines and gene therapies.

Spirax Group is headquartered in Cheltenham (UK). We have 37 strategically located manufacturing plants around the world and are committed to creating a safe and inclusive working culture for our 10,000 colleagues, operating in 66 countries and serving 110,000 customers globally.Β 

The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and we are a constituent of the FTSE 100 and the FTSE4Good Indexes.

Β 

* Eliminates scope 1 and 2 greenhouse gas emissions when connected to a green electricity source.

Β 

Further information can be found at spiraxgroup.com

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVDBGDXCGBDGUB
Date   Source Headline
8th Jun 20104:13 pmRNSDirector/PDMR Shareholding
4th Jun 20102:17 pmRNSHolding(s) in Company
1st Jun 20101:34 pmRNSTotal Voting Rights
28th May 20103:20 pmRNSDirector/PDMR Shareholding
25th May 20101:30 pmRNSAcquisition
21st May 20104:56 pmRNSDirector/PDMR Shareholding
14th May 20104:01 pmRNSDirector/PDMR Shareholding
14th May 201011:06 amRNSAGM Statement
11th May 20105:16 pmRNSDirector/PDMR Shareholding
11th May 20105:13 pmRNSAGM Statement
11th May 20101:00 pmRNSInterim Management Statement
4th May 201011:29 amRNSTotal Voting Rights
14th Apr 20104:04 pmRNSHolding(s) in Company
1st Apr 20109:13 amRNSTotal Voting Rights
29th Mar 20104:20 pmRNSDirector/PDMR Shareholding
29th Mar 20104:17 pmRNSHolding(s) in Company
25th Mar 201011:40 amRNSAnnual Financial Report
10th Mar 20104:21 pmRNSDirector/PDMR Shareholding
9th Mar 20105:16 pmRNSDirector/PDMR Shareholding
8th Mar 20106:15 pmRNSDirector/PDMR Shareholding
5th Mar 20104:18 pmRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNS2009 Preliminary Results
1st Mar 20106:07 pmRNSTotal Voting Rights
1st Feb 201011:13 amRNSTotal Voting Rights
1st Feb 201011:10 amRNSTotal Voting Rights - Replacement
18th Jan 20109:17 amRNSNotice of Results
8th Jan 20107:00 amRNSTrading Update
4th Jan 201010:36 amRNSTotal Voting Rights
4th Dec 20092:35 pmRNSHolding(s) in Company
1st Dec 20094:41 pmRNSDirector/PDMR Shareholding - Replacement
1st Dec 20093:58 pmRNSTotal Voting Rights
1st Dec 20093:56 pmRNSDirector/PDMR Shareholding
26th Nov 20091:49 pmRNSDirector Declaration
9th Nov 20093:42 pmRNSDirector/PDMR Shareholding
9th Nov 20097:00 amRNSInterim Management Statement
2nd Nov 20098:37 amRNSTotal Voting Rights
9th Oct 20093:21 pmRNSDirector/PDMR Shareholding
6th Oct 200912:34 pmRNSHolding(s) in Company
2nd Oct 20092:08 pmRNSHolding(s) in Company
2nd Oct 20098:30 amRNSAcquisition
1st Oct 200911:56 amRNSTotal Voting Rights
29th Sep 20094:29 pmRNSDirector/PDMR Shareholding
24th Sep 20091:49 pmRNSDirector/PDMR Shareholding
4th Sep 20092:24 pmRNSTotal Voting Rights
27th Aug 20093:32 pmRNSAcquisition
20th Aug 20097:00 amRNS2009 Half Year Results
5th Aug 20092:07 pmRNSNotice of Results
3rd Aug 20092:56 pmRNSTotal Voting Rights
16th Jul 20094:30 pmRNSDirectorate Change
2nd Jul 20093:02 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.